Aurora Cannabis (ACB) Other Accumulated Expenses (2021 - 2023)
Aurora Cannabis (ACB) posted quarterly Other Accumulated Expenses of $100631.4 for Q4 2023, down 98.91% year-on-year from $9.3 million in Q4 2022, and up 53.3% on a QoQ basis from $65641.9 in Q3 2023.
Aurora Cannabis (ACB) Other Accumulated Expenses (2021 - 2023) Analysis & Trends
Aurora Cannabis (ACB) has reported Other Accumulated Expenses for 3 consecutive years, with $100631.4 the latest figure, recorded in Q4 2023.
- Quarterly Other Accumulated Expenses fell 98.91% year-over-year to $100631.4 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $100631.4 (down 98.91% YoY) and the FY2023 annual result came in at $9.4 million, down 5.28% from the prior year.
- Other Accumulated Expenses grew to $100631.4 in Q4 2023 per ACB's latest filing, from $65641.9 in the prior quarter.
- Over the last five years, Other Accumulated Expenses for ACB reached as high as $13.4 million in Q4 2021 and fell as low as $65641.9 in Q3 2023.
- A 3-year average of $7.5 million and a median of $9.4 million in 2023 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2022 — Other Accumulated Expenses surged 6112.09% — and 2023, when it sank 99.32%.
- Year by year, Other Accumulated Expenses stood at $13.4 million in 2021, then tumbled by 30.72% to $9.3 million in 2022, then slumped by 98.91% to $100631.4 in 2023.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $100631.4, $65641.9, and $9.4 million for Q4 2023, Q3 2023, and Q2 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 100,631.37 |
| Sep 30, 2023 | 65,641.88 |
| Jun 30, 2023 | 9.41 Mn |
| Mar 31, 2023 | 9.30 Mn |
| Dec 31, 2022 | 9.26 Mn |
| Sep 30, 2022 | 9.64 Mn |
| Jun 30, 2022 | 9.85 Mn |
| Mar 31, 2022 | 9.82 Mn |
| Dec 31, 2021 | 13.37 Mn |
| Sep 30, 2021 | 9.66 Mn |
| Jun 30, 2021 | 8.85 Mn |
| Mar 31, 2021 | 158,019.82 |